HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significant hypertrophy regression with indapamide sustained release 1.5 mg.

Authors
JournalCardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners (Cardiovasc J S Afr) 2001 Feb-Mar Vol. 12 Issue 1 Pg. 52-3 South Africa
PMID11474686 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
  • Delayed-Action Preparations
  • Indapamide
Topics
  • Antihypertensive Agents (administration & dosage, therapeutic use)
  • Delayed-Action Preparations
  • Humans
  • Hypertrophy, Left Ventricular (drug therapy)
  • Indapamide (administration & dosage, therapeutic use)
  • Regression Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: